SURI Holdings — Simplify Propel Opportunities ETF
All 48 reported holdings of Simplify Propel Opportunities ETF (SURI) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| United States Treasury Bills | 92.93% | $64.45M |
| Plains GP Holdings LP | 44.55% | $30.89M |
| Achieve Life Science Inc | 5.02% | $3.48M |
| Phathom Pharmaceuticals Inc | 4.20% | $2.92M |
| Delcath Systems Inc. | 3.49% | $2.42M |
| Abeona Therapeutics Inc. | 3.23% | $2.24M |
| Celldex Therapeutics Inc. | 3.16% | $2.19M |
| Milestone Pharmaceuticals Inc | 2.58% | $1.79M |
| Oculis Holding AG | 2.56% | $1.77M |
| LeonaBio Inc. | 2.21% | $1.53M |
| Corcept Therapeutics Inc. | 2.19% | $1.52M |
| Kyverna Therapeutics Inc | 2.15% | $1.49M |
| Inventiva SA | 1.82% | $1.26M |
| Viridian Therapeutics Inc | 1.59% | $1.10M |
| Aquestive Therapeutics Inc | 1.40% | $972.26K |
| Vor Biopharma, Inc. | 1.38% | $954.62K |
| Orchestra BioMed Holdings Inc | 1.34% | $932.39K |
| Zevra Therapeutics Inc | 1.29% | $897.01K |
| Compass Pathways plc | 1.27% | $879.56K |
| Telesat Canada /Telesat LLC | 1.15% | $800.00K |
| Trevi Therapeutics Inc | 1.13% | $780.37K |
| Ocular Therapeutix Inc | 1.10% | $762.30K |
| Sab Biotherapeutics Inc | 1.03% | $717.09K |
| Upstream Bio Inc | 1.01% | $700.14K |
| Eyepoint Inc. | 0.99% | $689.95K |
| 4D Molecular Therapeutics Inc | 0.95% | $655.70K |
| Palisade Bio Inc | 0.88% | $612.50K |
| Zealand Pharma As | 0.82% | $568.78K |
| Kalaris Therapeutics, Inc. | 0.73% | $504.45K |
| Immunic Inc. | 0.70% | $487.21K |
| Coherus Oncology Inc. | 0.62% | $427.81K |
| Akero Therapeutics Inc | 0.62% | $426.63K |
| Corvus Pharmaceuticals Inc | 0.43% | $296.14K |
| Ovid Therapeutics Inc | 0.42% | $290.40K |
| Artiva Biotherapeutics, Inc. | 0.22% | $149.60K |
| Connect Biopharma Holdings Ltd. | 0.20% | $139.84K |
| Chinook Therapeutics Inc | 0.00% | $2.50K |
| Eiger BioPharmaceuticals Inc | 0.00% | $900 |
| Jasper Therapeutic Wts | 0.00% | $1 |
| Achieve Life Science Inc | 0.00% | $1 |
| Quoin Pharmaceutic Wts | 0.00% | $0 |
| Milestone Pharmace Wts | 0.00% | $2 |
| Milestone Pharmace Wts | 0.00% | $2 |
| Quoin Pharmaceutic Wts | 0.00% | $0 |
| Wts - Tenaya Therapeutics | 0.00% | $1 |
| Quoin Pharmaceutic Wts | 0.00% | $0 |
| Quoin Pharmaceutic Wts | 0.00% | $0 |
| Morgan Stanley & Co. LLC | -91.06% | $-63.15M |
SURI overview: performance, fees, allocation and SEC filings